These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 9537455

  • 21. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison.
    Tong MJ, Blatt LM, McHutchison JG, Co RL, Conrad A.
    Hepatology; 1997 Dec; 26(6):1640-5. PubMed ID: 9398010
    [Abstract] [Full Text] [Related]

  • 22. Discordance between serum alanine aminotransferase (ALT) and virologic response to IFN-alpha2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers.
    Blatt LM, Tong MJ, McHutchison JG, Russell J, Schmid P, Conrad A.
    J Interferon Cytokine Res; 1998 Feb; 18(2):75-80. PubMed ID: 9506457
    [Abstract] [Full Text] [Related]

  • 23. Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study Group.
    Lee WM, Reddy KR, Tong MJ, Black M, van Leeuwen DJ, Hollinger FB, Mullen KD, Pimstone N, Albert D, Gardner S.
    Hepatology; 1998 Nov; 28(5):1411-5. PubMed ID: 9794929
    [Abstract] [Full Text] [Related]

  • 24. Re-treatment of children with chronic hepatitis C who did not respond to interferon-alpha treatment.
    Gerner P, Hilbich J, Wenzl TG, Behrens R, Walther F, Kliemann G, Enninger A, Wirth S.
    J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):187-90. PubMed ID: 20512050
    [Abstract] [Full Text] [Related]

  • 25. Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic hepatitis C. Consensus Interferon Study Group.
    Keeffe EB, Dusheiko GM, Tong MJ, Hollinger FB, Heathcote EJ, McHutchison J, Albert D.
    Cytokines Cell Mol Ther; 1999 Dec; 5(4):211-6. PubMed ID: 10850385
    [Abstract] [Full Text] [Related]

  • 26. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
    Di Bisceglie AM, Thompson J, Smith-Wilkaitis N, Brunt EM, Bacon BR.
    Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
    [Abstract] [Full Text] [Related]

  • 27. The changes in quantitative HCV RNA titers during interferon alpha 2B therapy in patients with chronic hepatitis C infection.
    Tong MJ, Blatt LM, Conrad A, Hur Y, Russell J, El-Farra NS, Co RL.
    Am J Gastroenterol; 1998 Apr; 93(4):601-5. PubMed ID: 9576455
    [Abstract] [Full Text] [Related]

  • 28. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
    McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK.
    N Engl J Med; 1998 Nov 19; 339(21):1485-92. PubMed ID: 9819446
    [Abstract] [Full Text] [Related]

  • 29. Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients.
    Maddrey WC.
    Semin Liver Dis; 1999 Nov 19; 19 Suppl 1():67-75. PubMed ID: 10349694
    [Abstract] [Full Text] [Related]

  • 30. Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration. Consensus Interferon Study Group.
    Jensen DM, Krawitt EL, Keeffe EB, Hollinger FB, James SP, Mullen K, Everson GT, Hoefs JC, Fromm H, Black M, Foust RT, Pimstone NR, Heathcote EJ, Albert D.
    Am J Gastroenterol; 1999 Dec 19; 94(12):3583-8. PubMed ID: 10606323
    [Abstract] [Full Text] [Related]

  • 31. Interferon treatment in patients with chronic hepatitis C with normal alanine-aminotransferase activity.
    Yagura M, Murai S, Kojima H, Tokita H, Kamitsukasa H, Harada H.
    Hepatogastroenterology; 1999 Dec 19; 46(26):1094-9. PubMed ID: 10370673
    [Abstract] [Full Text] [Related]

  • 32. Treatment of acute hepatitis C with interferon alfa-2b.
    Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, Pastore G, Dietrich M, Trautwein C, Manns MP, German Acute Hepatitis C Therapy Group.
    N Engl J Med; 2001 Nov 15; 345(20):1452-7. PubMed ID: 11794193
    [Abstract] [Full Text] [Related]

  • 33. Utility of hepatitis C virus serotypes in predicting response to treatment of chronic hepatitis C. Consensus Interferon Study Group.
    Keeffe EB, Dusheiko GM, James SP, Mullen KD, Everson GT, Pimstone NR, Donovan J, Albert D.
    Cytokines Cell Mol Ther; 1999 Dec 15; 5(4):207-10. PubMed ID: 10850384
    [Abstract] [Full Text] [Related]

  • 34. Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels.
    Silverman AL, Piquette DL, Filipiak CL, Neill JS, Bayati N, Gordon SC.
    Am J Gastroenterol; 1997 Oct 15; 92(10):1793-5. PubMed ID: 9382038
    [Abstract] [Full Text] [Related]

  • 35. Consensus interferon: a novel interferon for the treatment of hepatitis C.
    Heathcote J.
    J Viral Hepat; 1998 Sep 15; 5 Suppl 1():13-8. PubMed ID: 9795924
    [Abstract] [Full Text] [Related]

  • 36. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group.
    Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K, Kakumu S, Iijima A, Urushihara A, Kiyosawa K, Okuda M, Hino K, Okita K.
    Hepatology; 1998 May 15; 27(5):1394-402. PubMed ID: 9581697
    [Abstract] [Full Text] [Related]

  • 37. Role of anti-interferon antibodies in breakthrough occurrence during alpha 2a and 2b therapy in patients with chronic hepatitis C.
    Leroy V, Baud M, de Traversay C, Maynard-Muet M, Lebon P, Zarski JP.
    J Hepatol; 1998 Mar 15; 28(3):375-81. PubMed ID: 9551673
    [Abstract] [Full Text] [Related]

  • 38. Extracorporeal photopheresis alone and with interferon-alpha2a in chronic hepatitis C patients who failed previous interferon therapy.
    O'Brien CB, Henzel BS, Moonka DK, Inverso J, Rook A.
    Dig Dis Sci; 1999 May 15; 44(5):1020-6. PubMed ID: 10235613
    [Abstract] [Full Text] [Related]

  • 39. A multicentre randomized controlled trial of recombinant interferon-alpha-2a in the treatment of patients with chronic hepatitis C.
    Komatsu M, Ono T, Nakajima K, Toyoshima I, Chiba M, Masamune O, Ohkubo S, Yoshida T, Yagisawa H, Komatsu K, Wakamatsu H, Yamada N, Watanabe H, Mukojima T, Goto M.
    Can J Gastroenterol; 1997 Oct 15; 11(7):579-82. PubMed ID: 9395758
    [Abstract] [Full Text] [Related]

  • 40. A randomized, double-blind, controlled trial of consensus interferon in the treatment of Chinese patients with chronic hepatitis C.
    Hwang SJ, Lee SD, Chan CY, Lu RH, Chang FY.
    Am J Gastroenterol; 1999 Sep 15; 94(9):2496-500. PubMed ID: 10484014
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.